@article{beachler_papich_andrews_dollen_ellis_withowski_bailey_2021, title={Clinical Outcome of Transcervical Infusion of a Combination of Procaine Penicillin and Gentamicin in Late-term Pregnant Mares}, volume={106}, ISSN={["1542-7412"]}, DOI={10.1016/j.jevs.2021.103727}, abstractNote={Transcervical intrauterine infusion of antibiotics may more effectively treat pathogens associated with fetal and neonatal disease in pregnant mares than standard systemic routes. The objective of this study was to assess the safety of transcervical antibiotic infusion by characterizing the gestational outcome in nine healthy pregnant pony mares following a single transcervical infusion of 2.4 million IU of procaine penicillin and 200 mg of gentamicin in a 10 mL volume during late gestation. Assessment of fetal-placental health was performed through serial measurement of the combined thickness of the uterus and placenta (CTUP) and fetal heart rate and mares and foals were closely monitored in the periparturient period. Fetal heart rate and CTUP remained unchanged after infusion, with no evidence of fluid accumulation or significant increase at the time-points 24, 48, and 72 hours. All mares foaled without complication 12-58 days after antibiotic infusion at a mean gestational age of 322.7 ± 12.7 days. Two out of nine foals displayed signs of mild neonatal maladjustment syndrome that responded to minimal supportive care and all foals survived to weaning without further complications.}, journal={JOURNAL OF EQUINE VETERINARY SCIENCE}, author={Beachler, Theresa M. and Papich, Mark G. and Andrews, Natalie C. and Dollen, Karen A. Von and Ellis, Katelyn E. and Withowski, Katie and Bailey, Christopher Scott}, year={2021}, month={Nov} }
 @article{beachler_gracz_morgan_bembenek bailey_borst_ellis_von dollen_lyle_nebel_andrews_et al._2021, title={Plasma metabolomic profiling of healthy pregnant mares and mares with experimentally induced placentitis}, volume={53}, ISSN={["2042-3306"]}, DOI={10.1111/evj.13262}, abstractNote={Abstract}, number={1}, journal={Equine Veterinary Journal}, author={Beachler, T.M. and Gracz, H.S. and Morgan, D.R. and Bembenek Bailey, S.A. and Borst, L. and Ellis, K.E. and Von Dollen, K.A. and Lyle, S.K. and Nebel, A.M. and Andrews, N.C. and et al.}, year={2021}, month={Jan}, pages={85–93} }
 @article{beachler_bailey_gracz_morgan_von dollen_ellis_gadsby_lyle_2020, title={Metabolomic Profile of Allantoic and Amniotic Fluid in Late-term Gestational Mares Characterized by H-1-nuclear Magnetic Resonance Spectroscopy}, volume={94}, ISSN={["1542-7412"]}, DOI={10.1016/j.jevs.2020.103235}, abstractNote={The amniotic and allantoic fluid compartments in the mare serve essential roles throughout pregnancy and parturition. Although the global metabolomic profile of amniotic fluid in women has been extensively characterized, current data for equine fetal fluids are limited. Therefore, the goal of this study was to characterize the global metabolomic profile of equine allantoic and amniotic fluid through nuclear magnetic resonance spectroscopy. Fetal fluids were collected between 270 and 295 days of gestation from 12 pregnancies through ultrasound-guided transabdominal puncture. A total of 24 samples (n = 10 allantoic fluid; n = 9 amniotic fluid; n = 5 admixed fluid) were analyzed by one-dimensional proton (1H) and two-dimensional (1H-13 C) nuclear magnetic resonance spectroscopy. Metabolites were integrated and compared between fluid types using a Kruskal-Wallis test at P < .05 significance. A total of 28 distinct metabolites were found in allantoic and admixed fluid, whereas 23 metabolites were identified in amniotic fluid. Allantoic fluid contained significant elevations (P < .05) in the metabolites betaine, creatine, creatinine, citrate, histidine, nitrophenol, tryptophan, π-methylhistidine, and unknown metabolite #1 compared with amniotic fluid, whereas amniotic fluid contained statistically increased concentrations of the metabolite lactate compared with allantoic fluid (P = .003).}, journal={JOURNAL OF EQUINE VETERINARY SCIENCE}, author={Beachler, Theresa M. and Bailey, C. Scott and Gracz, Hanna S. and Morgan, Davic R. and Von Dollen, Karen A. and Ellis, Katey E. and Gadsby, John E. and Lyle, Sara K.}, year={2020}, month={Nov} }
 @article{beachler_gracz_long_borst_morgan_nebel_andrews_koipillai_frable_bailey_et al._2019, title={Allantoic Metabolites, Progesterone, and Estradiol-17 beta Remain Unchanged After Infection in an Experimental Model of Equine Ascending Placentitis}, volume={73}, ISSN={["1542-7412"]}, DOI={10.1016/j.jevs.2018.11.014}, abstractNote={The objective of this study was to characterize the metabolomic profile of equine allantoic fluid in the pregnant mare with and without experimentally induced ascending placentitis with the goal of identifying biomarkers of this disease. We compared the onset of metabolomic changes with common modalities for diagnosis of ascending placentitis, including measurement of the combined thickness of the uterus and placenta (CTUP), hormonal profiling, and measurement of serum acute phase proteins. Ten pregnant pony mares were randomly divided into two groups: five healthy control mares (CONT) and five mares induced to develop ascending placentitis (PLAC) via inoculation with Streptococcus equi subsp. zooepidemicus bacteria at Days 280–285 of gestation. Allantoic fluid, whole blood, and serum were collected from both groups at 270–275 days of gestation and at the following time points postinoculation: 4 hours, Days 2, 4, 6, and 10. Differences between groups in identified metabolites, progesterone, estradiol-17β, lactate, and serum amyloid A (SAA) were assessed using an analysis of variance with repeated measures. A total of 27 metabolites were identified in allantoic fluid. No differences were detected between groups at any time point (P > .05) for any identified metabolite, progesterone, estradiol-17β, or lactate concentrations. Significant elevations in CTUP (P = .003) and SAA (P = .0001) were detected by Days 4 and 6 postinoculation, respectively. The results of this study established a database of equine allantoic fluid metabolites and confirmed the utility of uteroplacental ultrasound for detection of placentitis before the onset of hematologic changes.}, journal={JOURNAL OF EQUINE VETERINARY SCIENCE}, author={Beachler, Theresa and Gracz, Hanna and Long, Nathan M. and Borst, Luke and Morgan, David and Nebel, Amber and Andrews, Natalie and Koipillai, Joanna and Frable, Samantha and Bailey, Stasia Bembenek and et al.}, year={2019}, month={Feb}, pages={95–105} }
 @article{von dollen_jones_beachler_harris_papich_lyle_bailey_2019, title={Antimicrobial Activity of Ceftiofur and Penicillin With Gentamicin Against Escherichia coli and Streptococcus equi Subspecies zooepidemicus in an Ex Vivo Model of Equine Postpartum Uterine Disease}, volume={79}, ISSN={["1542-7412"]}, DOI={10.1016/j.jevs.2019.06.005}, abstractNote={The use of antimicrobials for the management of equine uterine disease is commonplace, with antibiotic selection generally based on empirical evidence or in vitro sensitivity results. However, the potential disconnect between these laboratory results and clinical efficacy in the mare raises concern for antibiotic failure and subsequent development of resistant organisms. In this work, we attempt to bridge this gap by using an ex vivo model of the equine postpartum uterus to quantitatively evaluate the antimicrobial activity of two commonly used antibiotic treatments in the mare (ceftiofur and penicillin with gentamicin). The activity of both of these treatments was evaluated in two different fluid environments (standard bacterial culture broth and equine postpartum uterine fluid) against clinical isolates of E. coli and S. zooepidemicus. Although treatment with ceftiofur was effective at reducing growth of S. zooepidemicus in equine postpartum uterine fluid, it did not reduce bacterial growth of E. coli. Treatment with procaine penicillin G with gentamicin achieved at least bacteriostatic activity against E. coli in both fluid types, and bactericidal activity against S. zooepidemicus in both fluid types. The intrauterine infusion of procaine penicillin G with gentamicin in cases of postpartum uterine disease caused by E. coli or S. zooepidemicus is supported by the results of this work.}, journal={JOURNAL OF EQUINE VETERINARY SCIENCE}, author={Von Dollen, Karen A. and Jones, Monica and Beachler, Theresa and Harris, Tonya L. and Papich, Mark G. and Lyle, Sara K. and Bailey, C. Scott}, year={2019}, month={Aug}, pages={121–126} }
 @article{ellis_council-troche_von dollen_beachler_bailey_davis_lyle_2019, title={Pharmacokinetics of Intrarectal Altrenogest in Horses}, volume={72}, ISSN={["1542-7412"]}, DOI={10.1016/j.jevs.2018.10.001}, abstractNote={Hospitalized pregnant mares being held nil per os (PO) because of medical or surgical events present a dilemma for pregnancy maintenance therapy, which commonly includes oral altrenogest. Rectal administration of medications is a recognized route for achieving systemic concentrations, but there are no data on the pharmacokinetics of rectal altrenogest administration in horses. The purpose of this study was to determine the pharmacokinetics of altrenogest following PO or per rectum (PR) administration in mares. Using a randomized two-way crossover study design, six horses received altrenogest (0.088 mg/kg; PO or PR q 24 hours for 5 days), with a 7-day washout period, and the concentrations of altrenogest were determined by an ultrahigh performance liquid chromatography with tandem mass spectrometry. Plasma concentrations persisted above presumed therapeutic concentrations for a mean of 36 hours (range 24-72 hours) and 5.5 hours (range 3-8 hours) for PO and PR administration, respectively. The calculated half-life (T ½) of PO administration (7.01 ± 3.13 hours) was correspondingly increased when compared to PR administration (2.82 ± 1.07 hours). Relative bioavailability of altrenogest following PR administration was only 5.47%. Altrenogest is rapidly absorbed following PR administration in the horse and reaches therapeutic concentrations, making this a viable method of treatment in NPO mares. The decreased bioavailability and shorter detection time suggest 0.088 mg/kg PR q 4-8 hours would be necessary to maintain therapeutic concentrations over a 24-hour period.}, journal={JOURNAL OF EQUINE VETERINARY SCIENCE}, author={Ellis, Katelyn E. and Council-Troche, R. McAlister and Von Dollen, Karen A. and Beachler, Theresa M. and Bailey, C. Scott and Davis, Jennifer L. and Lyle, Sara K.}, year={2019}, month={Jan}, pages={41–46} }
 @article{beachler_bailey_mckelvey_davis_edwards_diaw_vasgaard_whitacre_2016, title={Haemoperitoneum in a pregnant mare with an ovarian haematoma}, volume={28}, ISSN={["2042-3292"]}, DOI={10.1111/eve.12211}, abstractNote={Summary}, number={7}, journal={EQUINE VETERINARY EDUCATION}, author={Beachler, T. M. and Bailey, C. S. and McKelvey, K. A. and Davis, J. L. and Edwards, A. and Diaw, M. and Vasgaard, J. M. and Whitacre, M. D.}, year={2016}, month={Jul}, pages={359–363} }
 @article{mckelvey_beachler_ferris_diaw_vasgaard_bailey_2015, title={Vaginal prolapse in a pregnant Maine coon cat: a case report}, volume={56}, ISSN={["1748-5827"]}, DOI={10.1111/jsap.12310}, abstractNote={Vaginal prolapse is a condition characterised by excessive accumulation of mucosal oedema and protrusion of hyperplastic tissue through the vulva. It has been reported in ruminants and canines, but has not been characterised in felines. This report describes the history, clinical signs and treatment of a pregnant Maine coon cat with a Type III vaginal prolapse diagnosed approximately 54 days after the first day of mating. Prior to queening, the prolapse was reduced and retained using a vulvar cruciate suture. Due to the risk of dystocia and recurrence, a caesarean section with ovariohysterectomy was performed. Postoperatively, a stay suture was maintained in the vulva for 2 weeks, resulting in permanent reduction of the vaginal prolapse. To the authors’ knowledge, this case represents the first report of the successful management of vaginal prolapse in a pregnant cat.}, number={7}, journal={JOURNAL OF SMALL ANIMAL PRACTICE}, author={McKelvey, K. A. and Beachler, T. M. and Ferris, K. K. and Diaw, M. and Vasgaard, J. M. and Bailey, C. S.}, year={2015}, month={Jul}, pages={473–475} }
 @article{bailey_sper_schewmaker_buchanan_beachler_pozor_whitacre_2012, title={Uterine artery blood flow remains unchanged in pregnant mares in response to short-term administration of pentoxifylline}, volume={77}, ISSN={["1879-3231"]}, DOI={10.1016/j.theriogenology.2011.08.018}, abstractNote={The objective of this study was to use Doppler ultrasound technology to determine whether pentoxifylline administration increased uterine blood flow in normal pregnant pony mares. Thirteen pregnant pony mares between 18 and 190 d of gestation (mean ± SEM, 101 ± 55) were utilized for the study during two trial periods. In each trial, pentoxifylline (17 mg/kg by mouth every 12h, diluted in syrup) was administered to half of the mares for 3 d, while the other mares were treated with syrup only. Doppler measurements were obtained from the right and left uterine arteries from each mare for 2 d prior to treatment and throughout the treatment period. The mean Resistivity Index (RI), Pulsatility Index (PI), Uterine Artery Diameter (D), and Total Arterial Blood Flow (TABF) from each day were compared over time and between groups. Administration of pentoxifylline did not alter uterine blood flow parameters compared with controls (values for all treatment days combined were RI: 0.517 ± 0.014 vs 0.543 ± 0.016; PI: 0.876 ± 0.048 vs 0.927 ± 0.057; D: 0.388 ± 0.018 vs 0.379 ± 0.023 cm; and TABF: 35.26 ± 7.38 vs 30.73 ± 5.29 mL/min). Uterine blood flow increased over the course of the 5 d study, irrespective of treatment, and was higher in mares of greater gestational age than in early gestational mares (RI: r2 = 0.35; PI: r2 = 0.37; D: r2 = 0.66; and TABF: r2 = 0.67 – P < 0.00001). We concluded that any immediate benefits of pentoxifylline administration in the pregnant mare were not mediated through enhanced uterine artery blood flow.}, number={2}, journal={THERIOGENOLOGY}, author={Bailey, C. S. and Sper, R. B. and Schewmaker, J. L. and Buchanan, C. N. and Beachler, T. M. and Pozor, M. A. and Whitacre, M. D.}, year={2012}, month={Jan}, pages={430–436} }